10.1016/j.bioorg.2020.104373
The study focuses on the synthesis and evaluation of a series of novel 2-substituted quinoline-4-carboxylic acids derived from phenolic aldehydes, which were designed to target human dihydroorotate dehydrogenase (hDHODH), an enzyme crucial for cancer cell proliferation. These compounds were tested for their inhibitory activity against hDHODH, cytotoxicity against cancer cell lines (MCF-7, A549, A375), and a normal cell line (HaCaT), as well as their lipophilicity. The purpose of these chemicals was to serve as potential chemotherapeutic agents, with the aim of developing new drugs that can inhibit hDHODH, thereby disrupting pyrimidine biosynthesis and hindering cancer cell growth. The study also included molecular docking studies to understand the structural differences that contribute to the varying levels of activity among the synthesized compounds.